Precision Medicine in Inflammatory Bowel Diseases

Beitrag in einer Fachzeitschrift

Details zur Publikation

Autorinnen und Autoren: Fischer S, Neurath M
Zeitschrift: Clinical Pharmacology & Therapeutics
Jahr der Veröffentlichung: 2017
Band: 102
Heftnummer: 4
Seitenbereich: 623-632
ISSN: 0009-9236


Inflammatory bowel diseases (IBDs) are a lifelong condition of chronic, recurrent inflammation in the gut. The introduction of immunomodulators and biologic agents markedly improved the treatment of IBDs. Therefore, the use of biologics became an essential element in the rational therapy of IBDs. Various substances are currently evaluated in clinical trials, addressing different target structures and offering further approaches in the field of IBD. Regarding the growing number of treatment options, the need for prediction of therapy response became a necessity and is the subject of the present research.

FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Fischer, Sören
Transfusionsmedizinische und Hämostaseologische Abteilung in der Chirurgischen Klinik
Neurath, Markus Prof. Dr.
Lehrstuhl für Innere Medizin I


Fischer, S., & Neurath, M. (2017). Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics, 102(4), 623-632.

Fischer, Sören, and Markus Neurath. "Precision Medicine in Inflammatory Bowel Diseases." Clinical Pharmacology & Therapeutics 102.4 (2017): 623-632.


Zuletzt aktualisiert 2018-18-10 um 23:10

Link teilen